National Institute on Drug Abuse; Notice of Closed Meetings

Published date17 December 2019
Citation84 FR 68939
Record Number2019-27102
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 84 Issue 242 (Tuesday, December 17, 2019)
[Federal Register Volume 84, Number 242 (Tuesday, December 17, 2019)]
                [Notices]
                [Page 68939]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-27102]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Closed Meetings
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meetings.
                 The meetings will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; PHASE I: NIDA Avant-Garde Award Program for HIV/AIDS
                and Drug Use Research (DP1) (Mail) and Phase II: NIDA Avant Garde
                Award Program for HIV/AIDs and Drug Use Research (DP1) (Interview).
                 Date: December 18, 2019.
                 Time: 8:00 a.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy
                Chase, MD 20815.
                 Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
                Office of Extramural Affairs, National Institute on Drug Abuse,
                National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
                4238, MSC 9550, Bethesda, MD 20892, 301-402-6020,
                [email protected].
                 This notice is being published less than 15 days prior to the
                meeting due to the urgent need to meet timing limitations imposed by
                the intramural research review cycle.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; Mechanism for Time-Sensitive Drug Abuse Research
                (R21 Clinical Trial Optional).
                 Date: December 20, 2019.
                 Time: 1:00 p.m. to 3:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, Neuroscience Center
                Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852
                (Telephone Conference Call).
                 Contact Person: Susan O. McGuire, Ph.D., Scientific Review
                Officer, Office of Extramural Affairs, National Institute on Drug
                Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd.,
                Room 4245, Rockville, MD 20852, 301-435-1426,
                [email protected].
                 This notice is being published less than 15 days prior to the
                meeting due to the timing limitations imposed by the review and
                funding cycle.
                (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
                Abuse and Addiction Research Programs, National Institutes of
                Health, HHS)
                 Dated: December 11, 2019.
                Tyeshia M. Roberson,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-27102 Filed 12-16-19; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT